|
시장보고서
상품코드
2055015
파상풍 톡소이드 백신 시장 : 제품 유형별, 연령층별, 성별, 용도별, 최종사용자별, 유통 채널별, 지역별Tetanus Toxoid Vaccine Market, By Product Type (Combination Vaccines, and Monovalent Tetanus Toxoid ), By Age Group, By Gender By Application, By End User, By Distribution Channel, By Geography |
||||||
파상풍 톡소이드 백신 시장은 2026년에 62억 6,000만 달러로 추정되며, 2033년에 93억 6,000만 달러에 달할 것으로 예상됩니다. 2026-2033년까지 연평균 성장률(CAGR)은 5.9%를 기록할 전망입니다.
| 보고서 범위 | 보고서 상세 | ||
|---|---|---|---|
| 기준 연도: | 2025년 | 2026년 시장 규모: | 62억 6,000만 달러 |
| 과거 데이터 기간: | 2020-2024년 | 예측 기간: | 2026-2033년 |
| 2026-2033년까지 예측 기간 CAGR: | 5.90% | 2033년 시장 규모 예측: | 93억 6,000만 달러 |
전 세계 파상풍 톡소이드 백신 시장은 광범위한 예방접종 부문에서 중요한 부분을 차지하며, 파상풍균(Clostridium tetani)에 의한 파상풍 감염 예방에 중점을 두고 있습니다. 파상풍 톡소이드 백신은 면역계를 자극하여 파상풍 독소에 대한 항체를 생성하게함으로써 작용하며, 이 치명적인 질병에 대한 장기적인 예방 효과를 제공합니다. 이러한 백신은 단일 성분의 파상풍 독소(TT), 디프테리아·파상풍 혼합(DT), 디프테리아·파상풍·백일해 혼합(DTP), 추가 항원을 포함한 새로운 혼합 백신 등 다양한 제형을 통해 투여됩니다.
이 시장은 소아 및 성인 예방접종 프로그램을 모두 대상으로 하며, 정기 예방접종 일정은 일반적으로 영아기부터 시작되어 평생에 걸쳐 정기적인 추가 접종이 필요합니다. WHO와 유니세프를 비롯한 국제 보건 기구들은 파상풍 퇴치, 특히 산모와 신생아의 파상풍 퇴치를 최우선 과제로 삼고 있으며, 이것이 시장의 급격한 성장을 이끌고 있습니다. 백신 시장은 확립된 제조 공정, 입증된 안전성 프로필, 의료 종사자와 환자들 사이에서 널리 인정받고 있다는 점이 특징입니다. 유통 채널에는 정부 조달 프로그램, 민간 의료기관, 국제 원조 기관 등이 포함됩니다.
시장 역학
전 세계 파상풍 톡소이드 백신 시장은 각국 정부의 의무 예방접종 프로그램, 예방 가능한 질병에 대한 인식 제고, 개발도상국의 의료 인프라 확충 등 몇 가지 주요 시장 촉진요인에 힘입어 성장하고 있습니다. 세계보건기구(WHO)가 주도하는 산모 및 신생아 파상풍 퇴치를 위한 전 세계적 노력은, 특히 파상풍이 여전히 풍토병으로 남아 있는 저·중소득 국가에서 수요를 크게 증가시키고 있습니다. 특정 지역의 출산율 상승과 정기 예방접종의 보급 확대가 맞물려 시장 성장을 지속적으로 견인하고 있습니다. 또한, 여행 및 이민 증가에 따라 성인을 대상으로 한 추가 접종의 필요성이 높아지고 있을 뿐만 아니라, 부상 위험이 높은 산업 분야의 산업위생 요건 역시 시장의 추가적인 확대에 기여하고 있습니다.
그러나 시장에는 예방접종 수용을 가로막는 '백신 주저 현상', 외딴 지역의 백신 유통에 영향을 미치는 공급망 혼란, 비용 대비 효과가 높은 해결책을 추구하는 정부 조달 프로그램에 따른 가격 압박 등 뚜렷한 제약요인들이 존재합니다. 각국의 복잡한 규제 환경은 시장 진입 및 확장의 걸림돌이 되고 있으며, 또한 파상풍 토코이드 기술의 성숙도는 프리미엄 가격 책정 기회를 제한하고 있습니다. 콜드체인 유지 요건은, 특히 인프라가 부족한 지역에서 물류상의 문제를 야기하고 있습니다. 그럼에도 불구하고, 신흥 경제국에서의 예방접종 프로그램 확대, 편의성과 접종 순응도를 높이는 새로운 혼합 백신 개발, 성인 대상 백신 접종 프로그램에 대한 관심 증가로 인해 큰 성장 기회가 창출되고 있습니다. 백신 추적 및 알림 시스템을 위한 디지털 헬스 기술의 통합은 향후 성장의 길을 제시하고 있으며, 민관 파트너십은 의료 서비스가 충분히 제공되지 않는 계층을 대상으로 백신의 접근성과 합리적인 가격을 실현하기 위한 방안을 제시하고 있습니다.
본 조사의 주요 특징
- 본 조사에서는 각 부문의 잠재적 수익 기회를 파악하고, 이 시장에서 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 본 조사에서는 시장 촉진요인, 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업이 채택하는 경쟁 전략에 관한 중요한 인사이트를 제공합니다.
- 본 조사에서는 다음의 매개변수를 바탕으로 전 세계 파상풍 톡소이드 백신 시장의 주요 기업 개요을 작성했습니다. 구체적으로는 기업의 주요 성과, 제품 포트폴리오, 주요 하이라이트, 재무 실적, 전략입니다.
- 본 보고서의 인사이트를 활용함으로써, 기업의 마케팅 담당자 및 경영진은 향후 제품 출시, 제품 업그레이드, 시장 확대, 마케팅 전략에 관해 정보에 기반한 의사결정을 내릴 수 있게 됩니다.
- 전 세계 파상풍 톡소이드 백신 시장 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 금융 분석가 등 이 산업의 다양한 이해관계자를 대상으로 합니다.
- 이해관계자들은 전 세계 파상풍 토키소이드 백신 시장 분석에 활용되는 다양한 전략 매트릭스를 통해 의사결정을 수월하게 내릴 수 있습니다.
목차
제1장 조사 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 세계의 파상풍 톡소이드 백신 시장 : 제품 유형별, 2021-2033년
제5장 세계의 파상풍 톡소이드 백신 시장 : 연령층별, 2021-2033년
제6장 세계의 파상풍 톡소이드 백신 시장 : 성별, 2021-2033년
제7장 세계의 파상풍 톡소이드 백신 시장 : 용도별, 2021-2033년
제8장 세계의 파상풍 톡소이드 백신 시장 : 최종사용자별, 2021-2033년
제9장 세계의 파상풍 톡소이드 백신 시장 : 유통 채널별, 2021-2033년
제10장 세계의 파상풍 톡소이드 백신 시장 : 지역별, 2021-2033년
제11장 경쟁 구도
제12장 애널리스트의 제안
제13장 참고문헌과 조사 방법
KSM 26.06.18Tetanus Toxoid Vaccine Market is estimated to be valued at USD 6.26 Bn in 2026 and is expected to reach USD 9.36 Bn by 2033, growing at a compound annual growth rate (CAGR) of 5.9% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 6.26 Bn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 5.90% | 2033 Value Projection: | USD 9.36 Bn |
The global tetanus toxoid vaccine market represents a critical segment within the broader immunization landscape, focusing on preventing tetanus infections caused by the bacterium Clostridium tetani. Tetanus toxoid vaccines work by stimulating the immune system to produce antibodies against tetanus toxin, providing long-lasting protection against this potentially fatal disease. These vaccines are administered through various formulations including standalone tetanus toxoid (TT), combined diphtheria-tetanus (DT), diphtheria-tetanus-pertussis (DTP), and newer combination vaccines that include additional antigens.
The market encompasses both pediatric and adult vaccination programs, with routine immunization schedules typically beginning in infancy and requiring periodic booster doses throughout life. Global health organizations, including the WHO and UNICEF, have prioritized tetanus elimination, particularly maternal and neonatal tetanus, driving substantial market growth. The vaccine market is characterized by established manufacturing processes, proven safety profiles, and widespread acceptance among healthcare providers and patients. Distribution channels include government procurement programs, private healthcare facilities, and international aid organizations.
Market Dynamics
The global tetanus toxoid vaccine Market is propelled by several key drivers, including mandatory immunization programs implemented by governments worldwide, increasing awareness about preventable diseases, and growing healthcare infrastructure in developing nations. The World Health Organization's global initiative to eliminate maternal and neonatal tetanus has significantly boosted demand, particularly in low and middle-income countries where tetanus remains endemic. Rising birth rates in certain regions, coupled with expanding routine immunization coverage, continue to drive market growth. Additionally, increasing travel and migration patterns have heightened the need for booster vaccinations among adults, while occupational health requirements in industries with higher injury risks further expand the market.
However, the market faces notable restraints including vaccine hesitancy movements that challenge immunization uptake, supply chain disruptions affecting vaccine distribution in remote areas, and pricing pressures from government procurement programs seeking cost-effective solutions. Regulatory complexities in different countries create barriers for market entry and expansion, while the mature nature of tetanus toxoid technology limits premium pricing opportunities. Cold chain maintenance requirements pose logistical challenges, particularly in regions with inadequate infrastructure. Nevertheless, significant opportunities emerge from expanding immunization programs in emerging economies, development of new combination vaccines that enhance convenience and compliance, and increasing focus on adult vaccination programs. The integration of digital health technologies for vaccine tracking and reminder systems presents additional growth avenues, while public-private partnerships offer pathways to improve vaccine accessibility and affordability in underserved populations.
Key Features of the Study
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, market trends, regional outlook, and competitive strategies adopted by key players.
- It profiles key players in the global tetanus toxoid vaccine market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies.
- Key companies covered as a part of this study include Sanofi Pasteur, GlaxoSmithKline (GSK), Pfizer Inc, Serum Institute of India Pvt Ltd, Bharat Biotech, Biological E Limited, Avalon Pharma Pvt. Ltd, Intervax, Grifols, Merck and Co Inc, KM Biologics, PT Bio Farma, Indian Immunologicals Ltd, and AJ Vaccines.
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
- The global tetanus toxoid vaccine market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global tetanus toxoid vaccine market.
Market Segmentation
- Product Type Insights (Revenue, USD Bn, 2021 - 2033)
- Combination Vaccines
- Diphtheria, Tetanus, Pertussis (DTP/DTwP/DTaP)
- Tetanus, Diphtheria (Td)
- Tetanus, Diphtheria, Pertussis (Tdap)
- Tetanus, Diphtheria, Pertussis, Polio (DTaP-IPV / Tdap-IPV)
- Tetanus, Diphtheria, Pertussis, Haemophilus influenzae type b, Hepatitis B (Pentavalent: DTP-HepB-Hib)
- Tetanus, Diphtheria, Pertussis, Polio, Haemophilus influenzae type b (Hexavalent: DTaP-IPV-Hib-HepB)
- Monovalent Tetanus Toxoid (TT)
- Age Group Insights (Revenue, USD Bn, 2021 - 2033)
- Pediatric
- Adult
- Geriatric
- Gender Insights (Revenue, USD Bn, 2021 - 2033)
- Male
- Female
- Application Insights (Revenue, USD Bn, 2021 - 2033)
- Routine Immunization (Primary Series and Boosters)
- Wound Management (Post-exposure Prophylaxis)
- Maternal Immunization (Preventing Maternal and Neonatal Tetanus)
- Travel Immunization
- Occupational Health (High-risk professions)
- Others (Rehabilitation Centers, etc.)
- End User Insights (Revenue, USD Bn, 2021 - 2033)
- Hospitals
- Clinics and Vaccination Centers
- Community Health Centers
- Occupational Health Settings
- Others (Academic and Research Institutions)
- Distribution Channel Insights (Revenue, USD Bn, 2021 - 2033)
- Public Sector
- Private Sector
- Regional Insights (Revenue, USD Bn, 2021 - 2033)
- North America
- U.S.
- Canada
- Latin America
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- South Africa
- North Africa
- Central Africa
- Key Players Insights
- Sanofi Pasteur
- GlaxoSmithKline (GSK)
- Pfizer Inc
- Serum Institute of India Pvt Ltd.
- Bharat Biotech
- Biological E Limited
- Avalon Pharma Pvt. Ltd
- Intervax
- Grifols
- Merck and Co Inc.
- KM Biologics
- PT Bio Farma
- Indian Immunologicals Ltd.
- AJ Vaccines
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Global Tetanus Toxoid Vaccine Market, By Product Type
- Global Tetanus Toxoid Vaccine Market, By Age Group
- Global Tetanus Toxoid Vaccine Market, By Gender
- Global Tetanus Toxoid Vaccine Market, By Application
- Global Tetanus Toxoid Vaccine Market, By End User
- Global Tetanus Toxoid Vaccine Market, By Distribution Channel
- Global Tetanus Toxoid Vaccine Market, By Region
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Driver
- Restraint
- Opportunity
- Impact Analysis
- Key Developments
- Regulatory Scenario
- Product Launches/Approvals
- PEST Analysis
- PORTER's Analysis
- Merger and Acquisition Scenario
- Industry Trends
4. Global Tetanus Toxoid Vaccine Market, By Product Type, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Combination Vaccines
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Diphtheria, Tetanus, Pertussis (DTP/DTwP/DTaP)
- Tetanus, Diphtheria (Td)
- Tetanus, Diphtheria, Pertussis (Tdap)
- Tetanus, Diphtheria, Pertussis, Polio (DTaP-IPV / Tdap-IPV)
- Tetanus, Diphtheria, Pertussis, Haemophilus influenzae type b, Hepatitis B (Pentavalent: DTP-HepB-Hib)
- Tetanus, Diphtheria, Pertussis, Polio, Haemophilus influenzae type b (Hexavalent: DTaP-IPV-Hib-HepB)
- Diphtheria, Tetanus, Pertussis (DTP/DTwP/DTaP)
- Monovalent Tetanus Toxoid (TT)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
5. Global Tetanus Toxoid Vaccine Market, By Age Group, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Geriatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
6. Global Tetanus Toxoid Vaccine Market, By Gender, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Male
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Female
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
7. Global Tetanus Toxoid Vaccine Market, By Application, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Routine Immunization (Primary Series and Boosters)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Wound Management (Post-exposure Prophylaxis)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Maternal Immunization (Preventing Maternal and Neonatal Tetanus)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Travel Immunization
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Occupational Health (High-risk professions)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Rehabilitation Centers, etc.)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
8. Global Tetanus Toxoid Vaccine Market, By End User, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Clinics and Vaccination Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Community Health Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Occupational Health Settings
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Others (Academic and Research Institutions)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
9. Global Tetanus Toxoid Vaccine Market, By Distribution Channel, 2021 - 2033, (USD Bn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022 - 2033
- Segment Trends
- Public Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
- Private Sector
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033, (USD Bn)
10. Global Tetanus Toxoid Vaccine Market, By Region, 2021 - 2033, Value (USD Bn)
- Introduction
- Market Share (%) Analysis, 2026, 2028 & 2033, Value (USD Bn)
- Market Y-o-Y Growth Analysis (%), 2022 - 2033, Value (USD Bn)
- Regional Trends
- North America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- U.S.
- Canada
- Latin America
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Brazil
- Argentina
- Mexico
- Rest of Latin America
- Europe
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- Germany
- U.K.
- Spain
- France
- Italy
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- China
- India
- Japan
- Australia
- South Korea
- ASEAN
- Rest of Asia Pacific
- Middle East
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country, 2021 - 2033, Value (USD Bn)
- GCC Countries
- Israel
- Rest of Middle East
- Africa
- Introduction
- Market Size and Forecast, By Product Type, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Age Group, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Gender, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Application, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By End User, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Distribution Channel, 2021 - 2033, Value (USD Bn)
- Market Size and Forecast, By Country/Region, 2021 - 2033, Value (USD Bn)
- South Africa
- North Africa
- Central Africa
11. Competitive Landscape
- Sanofi Pasteur
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- GlaxoSmithKline (GSK)
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Serum Institute of India Pvt Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Bharat Biotech
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Biological E Limited
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Avalon Pharma Pvt. Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Intervax
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Grifols
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Merck and Co Inc.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- KM Biologics
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- PT Bio Farma
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Indian Immunologicals Ltd.
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- AJ Vaccines
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
12. Analyst Recommendations
- Wheel of Fortune
- Analyst View
- Coherent Opportunity Map
13. References and Research Methodology
- References
- Research Methodology
- About us
